This finding likely involves the induction of DNA damage and P53 activation by anti-cancer drugs, which culminates in tumor cell apoptosis that is inhibited by TIMP-1-mediated activation of FAK/PI3k/Akt signaling [7], [17]. This evidence concerns the gene TP53 and cancer.